| Literature DB >> 29988356 |
Anke Joas1, Miriam Schöpel1, Madlen David2, Maribel Casas3,4,5, Gudrun Koppen6, Marta Esteban7, Lisbeth E Knudsen8, Martine Vrijheid3,4,5, Greet Schoeters6, Argelia Castaño Calvo7, Gerda Schwedler2, Marike Kolossa-Gehring2, Reinhard Joas1.
Abstract
BACKGROUND: To date Health information (HI) in the European Union does not comprise indicators or other information related to impacts of hazardous chemicals in consumer products, food, drinking water or air on the health status of the population. Therefore, we inventorised and evaluated the potential of environmental health surveillance and research data sources in the European population to provide HBM-based indicators of internal human exposure and health impact of relevant chemicals.Entities:
Keywords: Birth cohorts; Chemical contaminants; Environmental health; HBM; HES; Health information
Year: 2018 PMID: 29988356 PMCID: PMC6022511 DOI: 10.1186/s13690-018-0272-6
Source DB: PubMed Journal: Arch Public Health ISSN: 0778-7367
Overview on European cross-sectional HBM studies
| Scientific Focus | Size | Age groups | Matrix | Chemicals | Frequency | |
|---|---|---|---|---|---|---|
| Belgium FLEHS | Wide range of exposure burden in Flanders, reference values | 650 | new-borns and their mothers 14–15 y/o adults 20–40 y/o adults | Cord blood, blood, urine hair | metals, dioxins, PCBs, PAHs, dichlorodiphenyltrichloroethane, phthalates, musks, parabens and organophosphate pesticides, flame retardants | 4× since 2002 |
| Czech Republic EHMS | Core set of chemicals measured in the Czech population | 1290 | 18–58 y/o adults 8–10 y/o children breastfeeding primiparas g | Blood urine, breastmilk, teeth | metals, PCBs, cotinine, organochlorines | Annually since 1994 |
| France ENNS | Wide range of exposure burden on children and adults in France | 4790 | 3–17 y/o children 18–74 y/o adults | Blood, urine hair | metals, PCBs, organochlorines, pyrethroids, organophosphates | Once, 2006–2007 |
| Germany GerES | Wide range of exposure burden on adults, children and adolescents in Germany, reference values | 1790–4822 | adults: GerES I-III: 18–79 y children and adolescents: GerES III-V: 6–17 y (GerES III) 3–14 y (GerES IV) 3–17 y (GerES V) (in preparation: adults: GerES VI: 18–79 y) | Blood urine | metals, organochlorines, cotinine, organophosphates, chlorophenols, polycyclic aromatic hydrocarbons, pyrethroids, phthalates, bisphenol A, phenanthrenes, plasticiser substitutes, pyrrolidones | 5× since 1985 |
| Italy PROBE | POPs´ and metals’ internal dose in adults to highlight the environmental impact on the health of Italian population | 1423 | 18–65 y/o adults | Blood | 20 metals, POPs | 2× (both 2008) |
| Slovenia HBM program | Pilot study for establishing reference values for selected chemicals in Slovenia | 320 | Breast feeding first time mothers (20–35 y/o) and their male partners | Blood breast milk | metals, PCBs, PBDEs, PCDDs, PCDFs | 2× (2007, 2011) |
| Spain- BIOAMBI-ENT.ES | Estimation of levels of heavy metals and other substances on the Spanish active workforce | 1892 | Participants (≥16 y/o) | Blood, urine hair | metals, PCBs, cotinine, organochlorines, PAHs, PBDEs, perfluorinated alkyl substances, phthalates, DINCH | Once, 2009–2010 |
| Spain BEA | Study of the adolescents to environmental pollutants and determinant factors | 500 | Adolescents (14–16 y/o) | Blood, urine, hair | Metals, bisphenols, triclosan, phthalates and others organic pollutants | Once, 2017 |
| DEMOCOPHES | To test the feasibility of harmonized HBM in Europe | 1844 (~ 240 per country) | Children 6–11 y/o and their mothers (≤ 45 y/o) | Hair urine | phthalates, cadmium, mercury | Once, 2010–2012 |
Fig. 1Starting dates of (only selected) European birth cohorts and HBM programmes (abbreviations), and related harmonisation efforts (logos)
Overview of indicator data on environmental exposure, health and data of human biomarkers that are available for environmental health research
| Indicators and/or relevant information within European programs | Biomarkers | POPs: dioxins furans, PCBs | Metals: lead, arsenic, mercury cadmium | Biocides: pesticides, herbicides fungicides | Flame retardants: polybrominated/fluorinated diphenyl ethers, organochlorines, organophosphates | Plasticizers/plastic compounds: (bis-) phenols, phthalates | Coatings: perfluorinated compounds | Personal care products: Polycyclic musks, disinfectants, trihalomethans, sunscreens | Smoking: Cotinine and metabolites | VOCs and VOCs: benzene, PAHs | Acrylamide & metabolites | Mycotoxins aflatoxin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||||
|
| ||||||||||||
|
| ||||||||||||
| Emission of acidifying substances, O3, prim.PM, sec.PM (EEA), PM10(ENHIS) |
| |||||||||||
| Exceedance of air quality limit values in urban areas (EEA) |
| |||||||||||
| Particulate matter exposure PM10 (ECHI55) | x | x | ||||||||||
|
| ||||||||||||
| Indoor air (IPChem) |
|
|
|
|
|
|
|
| ||||
|
| ||||||||||||
| oxygen consuming substances (EEA) + nutrients in freshwater (EEA) |
| |||||||||||
| contaminants in water (national databases) | ||||||||||||
|
|
|
|
| |||||||||
|
| ||||||||||||
| chemical contaminants: due to food production, distribution, packaging or consumption (EFSA) |
|
|
|
|
|
| ||||||
| additives (EFSA) | ||||||||||||
| chemical residues: pesticides, hormones (EFSA) |
| |||||||||||
|
| ||||||||||||
| Consumer goods direct contact, other than food (REACH1) |
|
|
|
| ||||||||
|
| ||||||||||||
| pollutant release to air, water and waste from ind. Facilities (EEA) |
|
|
|
|
|
| ||||||
|
| ||||||||||||
| household consumption (EEA) |
|
| ||||||||||
| diversion waste from landfill (EEA) |
|
|
| |||||||||
|
| ||||||||||||
| work-related health risks (ECHI53) |
|
|
|
|
|
|
|
| ||||
|
| ||||||||||||
|
| ||||||||||||
| smoking-related deaths (ECHI15) | x | |||||||||||
| regular smokers (ECHI44), pregnant women smoking (ECHI45) | x | |||||||||||
|
| ||||||||||||
| blood pressure (ECHI43) | x | x | x | |||||||||
|
| ||||||||||||
| cancer incidence (ECHI20) | x | x | x | x | x | x | ||||||
|
| ||||||||||||
| diabetes:self-reported+register-based prevalence (ECHI21A and B) | x | x | x | x | x | x | x | x | ||||
|
| ||||||||||||
| Time to pregnancy (HBM) | x | x | x | x | x | x | x | |||||
| total fertility rate (ECHI4) | x | x | x | x | x | x | x | |||||
| Sexual maturation (HBM) | x | x | x | x | x | x | x | |||||
|
| ||||||||||||
| asthma, self-reported +register-based prevalence (ECHI26A and B) | x | x | x | x | x | x | x | x | x | x | x | |
| COPD, self-reported +register-based prevalence (ECHI27A and B) | x | x | x | x | x | x | x | x | x | x | ||
| Allergies, allergic rhinitis, asthma, eczema, food allergy (HBM) | x | x | x | x | x | x | x | x | x | x | x | |
| Infections (respiratory and others) | x | x | x | x | x | x | x | x | x | x | x | |
|
| ||||||||||||
| dementia/Alzheimer (ECHI22) | x | x | x | x | x | |||||||
| depression, self-reported +register-based prevalence (ECHI23A and B) | x | x | x | x | x | |||||||
| cognitive tests (HBM) | x | x | x | x | x | |||||||
| behaviour, autism, hyperactivity disorders (HBM) | x | x | x | x | x | |||||||
| growth and obesity, metabolic syndrome (HBM) | x | x | x | x | x | x | x | x | x | |||
|
| ||||||||||||
| Spontaneous abortion/stillbirths/terminations (HBM) | x | x | x | x | x | x | ||||||
| Gestational age (HBM) | x | x | x | x | x | x | ||||||
| (low) birth weight (ECHI28) | x | x | x | x | x | x | x | x | ||||
| mortality, birth weight, plurality (C1-C5) | x | x | x | x | x | x | x | x | ||||
| Prevalence +deaths of selected congenital anomalies (R1, R3) | x | x | x | x | x | x | ||||||
| Distribution of Apgar score at 5 min (R2) | x | x | x | x | x | x | x | x | x | x | ||
| Prevalence of cerebral palsy (R4) | x | x | x | |||||||||
|
| ||||||||||||
| Maternal mortality ratio (C6, C7) | ||||||||||||
| Incidence of severe maternal morbidity (R6) | x | x | x | x | x | x | x | x | x | x | ||
| Mode of delivery (HBM) | x | |||||||||||
|
| ||||||||||||
| body mass index (ECHI42) | X | x | x | x | x | X | ||||||
Crosses in the table suggest which indicators/data can be linked in order to study either the human exposure route leading to measurable internal concentrations measured in humans (human biomarkers, in columns) and furthermore linking these biomarkers with health indicators/data (Note: EEA = Environmental Core Indicator; (ECHI = European Core Health indicators (ECHI nr); Health indicators of EUROPERISTAT (C = core, R = recommended); effect biomarkers of HBM studies/cohorts (HBM); IPCheM = Information Platform for Chemical Monitoring for inventarisation of indoor, HBM, food/feed and environmental data)
Important parameter in HBM and HES study design
| Key parameter | HBM studies | HES (according to EHESa) |
|---|---|---|
| Study population | General adult population: | General adult population: |
| Questionnaire topics | Residential environment and residence | Based on the EHIS. |
| Sample matrixb | Blood (10/11) | Blood |
| Tested markers | Heavy Metals: Cd, Pb, Hg | Biological |
a http://www.ehes.info/
bSample matrix data assessed by Table 4 of Supplemental material